Özgeçmiş
Hematoloji
Hematolojik Onkoloji
Aferez
Kök Hücre Nakli
Sorularınız
Seminerler
Ders 2008
Homer
Linkler
Son Gelişmeler
Halk İçin Hematoloji
Aktiviteler
 
   
   
   

Geri


YABANCI YAYINLAR

  1. Şardaş S, Çok İ, Şardaş OS, İlhan O, Karakaya AE Polimorphic N-acetylation capacity in breast cancer patient. Int J Cancer 46:1138-1139, 1990

  2. Şardaş O.S., Koç H., İlhan O., Akan H., Beksaç M.: Hepatic failure after bone marrow transplantation. Blood 70. 2265, 1990.

  3. Şardaş O.S., Beksaç M., Koç H., İlhan O., Akan H., Gürman G. Tumor Necrosis Factor a in human bone marrow recipients. Blood 76 (12): 2639, 1990.

  4. Şardaş OS, Koç H, İlhan O, Akan H, Beksaç M: Hepatic Failure After Bone Marrow Transplantation. Blood 75(11):2265, 1990. (Letter)

  5. Şardaş OS, Beksaç M, Koç H, İlhan O, Akan H, Gürman G: Tumor Necrosis Factor in Human Bone Marrow Recipients. Blood, 67(12):2639, 1990. (Letter)

  6. Beksaç M, Özcan M, Koç H, Akan H,İlhan O, Şardaş O. Circulating endogenous granulocyte colony-stimulating factor levels after bone marrow transplantation. Blood 79: 2946-2947, 1992. (Letter)

  7. Beksaç M, Akan H, Koç H, İlhan O, Ertürk Ş, Güneyli A, İkizünal Y, Şardaş O. Glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols. Med Oncol & Tumor Pharmacother Vol 9(2):101-105,1992

  8. Akan H, Koç H,,Beksaç M, İlhan O, Gürman G, Aydoğdu İ, Şardaş OS.: Case Report: Complications of Bone Marrow Transplantation, A long way to run. Libri Oncol, 22(3):219-221, 1993

  9. Beksaç M, Ertürk Ş, Akan H, Koç H, İlhan O. The clinical correlations of serum tumour necrosis factor-alpha levels in acute leukemias. A predictor of response and relapse? Leukemia, 7(11): 1773-1776, 1993

  10. Karakaya AE, Çok İ, Şardaş S, Gürman G, İlhan O Erythrocyte membrane stearic to oleic acid ratio in lymphoma patients. Pharmacology Toxicology 73: Supl 2:70, 1993

  11. Beksaç M, Özcan M, Koç H, Akan H, İlhan O.: Relevance of serum G-CSF levels in bone marrow transplantation patients. Experimental Hematology 23(6): 480-481, 1994

  12. Arslan Ö.,Akan H.,Beksaç M.,İlhan O.,Koç H.,Konuk N.: Terminal Deoxytidyl Transferase positivity in acute nonlymphoblastic leukemia. Leukemia 8 (6) :1067 , 1994. (Letter)

  13. Akan H, Beksaç M, Aydoğdu İ, Koç H, İlhan O, Özcan M.: Peripheral T Cell Receptors ab and gd in patients with Hodgkin's lymphoma. Br J Haematol 87(3):544-547 ,1994

  14. İlhan O, Beksaç M, Koç H, Akan H, A. Keskin, Arslan Ö, Gürman G, Özcan M, Konuk N, Uysal A.: HLA DR frequency in Turkish aplastic anemia patients and the impact of HLA DR2 positivity in response rate in patients receiving immunosuppressive therapy. Blood 86(5): 2055, 1995. (letter)

  15. İlhan O, Aydoğdu İ, Beksaç M, Koç H, Akan H, Konuk N, Uysal A.: Combination therapy in Aplastic anemia. Indian J Med Res (102) :143-146,1995

  16. İlhan İ, Erekul S, Ateşalp S, İlhan O, Akar N. p53 codon 213AG polymorphism in Turkish population. Pediatric Hematology and Oncology 12:499-501, 1995

  17. Gürman G, Kahveci G, Akan H, İlhan O, Koç H, Beksaç M, Konuk N, Uysal A.: Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia. Bone Marrow Transplant 15: 485-488, 1995

  18. İlhan O, Uysal A, Aydoğdu İ, Beksaç M, Akan H, Koç H: Mitoxantrone and cytosine arabinoside in previously untreated patients with acute non-lymphocytic leukemia. Haematologica 27(2):93-97, 1996

  19. Arslan Ö, Akan H, Koç H, Beksaç M, İlhan O, Özcan M, Yalçın S, Gürman G, Konuk N, Uysal A Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen. Bone Marrow Transplantation 18:261-264, 1996

  20. Arslan Ö, Akan H, Beksaç M, Özcan M, Koç H, İlhan O, Konuk N, Uysal A Lack of prognostıc value of CD34 in adult AML. Leukemia and Lymphoma, 1996 (letter)

  21. Koç H, Gürman G, Arslan Ö, Özcan M, Akan H, İlhan O, Konuk N, Beksaç M, Uysal A. Is there an increased risk of graft versus host disease after allogeneic peripheral blood stem cell transplantation? Blood 88(6):2362-4, 1996

  22. İlhan O, Koç H, Akan H, Gürman G, Arslan Ö, Özcan M, Arıkan N, Sencer H, Konuk N, Uysal A, Beksaç M Hemorragic cysttits as a complication of bone marrow transplantation J of Chemotherapy 9:56-61, 1996

  23. İlhan O, Beksac M, Arslan Ö, Özcan M, Koç H, Akan H. HLA DR2: A predictive marker in response to cyclosporine therapy in aplastic anemia Int J Hematol 66:291-295,1997

  24. Koç H, Arslan Ö, Gürman G, Akan H, Özcan M, İlhan O, Aydoğdu İ, Arat M, Beksaç M, Konuk N, Uysal A. The use of high dose chemotherapy plus granulocyte colony stimulating factor for the salvage of refractory ort resistant relapse malignant lymphoma patients without stem cell support. Acta Haematol 98(3):136-139 1997.

  25. Akan H, Koç H, Arslan Ö, Beksaç M, İlhan O, Gürman G, Özcan M. Febrile neutropenia in a bone marrow transplantation center. Int J of Antimicrob Agents 8:127-130 1997

  26. İlhan O, Akan H, Koç H, Gürman G, Arslan Ö, Özcan M, Erdi H, Erdem C, Konuk N, Uysal A, Beksac M Incidence of graft versus host disease in allogeneic bone marrow transplantation in a single center study from Turkey. Hematol Cell Ther 39:133-36, 1997

  27. Üstün C, Koç H, Karayalçın S, Akyol H, Gürman G, İlhan O, Akan H, Özcan M, Arslan Ö, Konuk N, Uysal A,. Hepatitis B Virus infection in allogeneic bone marrow transplantation. Bone Marrrow Transplantation 20:289-96, 1997

  28. Koç H. Gürman G,Arslan Ö, Özcan M. Dilek İ, Akan H, İlhan O, Konuk N, Beksaç M, Uysal A. Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients? Journal of Chemotherapy 9(5):371-376 1997.

  29. Aydoğdu İ, Koç H. İlhan O, Gürman G, Akan H, Beksaç M, Konuk N, Uysal A, Özerol E. Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma. Hematologia 28(4):207-213 1997.

  30. Dilek İ, Demirer T, Üstün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Özcan M, İlhan O, Akan H. Acquired ichthyosis associated with chronic graft versus host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant 21:1159-1161 1998.

  31. Arslan Ö, Gürman G, Dilek İ, Özcan M, Koç H, İlhan O, Akan H, Konuk N, Uysal A, Beksaç M. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey Haematologia 29(1):59-63 1998.

  32. Arslan Ö, Seferoğlu A, Gürman G, İlhan O, Koç H. Resistant graft faılure overcome with allogeneic peripheral blood plus bone marrow stem cells. Haematologia 29(1):47-51, 1998.

  33. Beksaç M, Arslan Ö, Koç H, Akan H, İlhan O, Arat M, Özcan M, Gürman G, Konuk N, Uysal A. Randomized unicenter trial for comparison of three regimen in de novo adult acute nonlymphoblastic leukemia. Medical Oncol 15:183-190 1998.

  34. Arslan Ö, Üstün C, Arat M, Çelebi H, Akan H, Beksaç M, İlhan O, Gürman G, Özcan M, Konuk N, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation in acute nonlymphoblastic leukemia. Hematological Oncology 1999 (in press)

  35. Üstün C, Arslan Ö, Beksaç M, Koç H, Gürman G, Özçelik T, Yılmaz B, İlhan O, Akan H, Özcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek İ, Çelebi H, Çoşkun HŞ. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, a focus on the incidence of GVHD and relapse. The Biology of Blood and Marrow Transplantation 1999;5(1):28-35

  36. Üstün C, İdilman R, Gürman G, Özcan M, Akyol G, Akan H, İlhan O, Beksaç M, Uysal A, Konuk N, Karayalçın S, Aylar Poyraz A, Thiel D V and Koç H. Hematopoİetİc stem cell transplantation in patients with non-replicative hepatitis B virus carrier is safe. Journal of Hepatology (in press)

  37. Üstün C, Çelebi H, Arat M, Özcan M, Dilek İ, Gürman G, İlhan O, Koç H. Pure Red Cell Aplasia as a Complication of an ABO-incompatible Allo-PBSCT: successful sequential treatment with plasma exchange, high dose prednisolone, danazol and erythropoietin Ther Apher (accepted)

  38. İlhan O, Arslan Ö, Arat M, Beksaç M, Akan H, Koç H, Dilek İ, Özcan M, Gürman G, Konuk N, Uysal A. The impact of CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation. Transfusion Science 20:69-71,1999

  39. J.Marsh, H.Schrezenmeier, P.Marin, O.İlhan, P.Ljungman, S. McCann, G.Socie, A.Tichelli, J.Passweg, J.Hows, A.Raghavachar, A.Locasciulli, A.Bacigalupo, on behalf of the EBMT severe aplastic anemia working party.. Prosective randomized mulitcenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with non-severe aplastic anemia:A report from the European Blood and Marrow Transplant (EBMT) Sever Aplastic Anemia Working Party Blood 93:2191-2195, 1999

  40. O.İlhan, N.Üstkent, Ö.Arslan, M.Arat, F.Özkalemkaş, G.Öztürk, S.Beşışık Kalayoğlu, A.Özet, M.Tombloğlu, M.Arpacı, E.Ovalı, S.Anak. On Behalf of Turkish Apheresis Group. National Survey of Hemapheresis practice in Turkey (1998). Transfucion Science 22:195-201,2000.

  41. Ö.Arslan, H.Akan, M.Arat, K.Dalva, M.Özcan, G.Gürman, O.İlhan, N.Konuk, M.Beksaç, A.Uysal, H.Koç: Soluble adhesion molecules (sICAM-1, sL-Selectin, sCD44) in healthy allogeneic peripheral blood stem cell donors primed with recombinant granulocyte-colony stimulating factor. Cytotherapy 2(4):259-265, 2000.

  42. Ö.Arslan, H.Ş.Çoşkun, M.Arat, H.Çelebi, M.Özcan, G.Gürman, C.Üstün,T.Demirer, H.Akan, O.İlhan, N.Konuk, M.Beksaç, A.Uysal, H.Koç. Allogeneic peripheral blood stem cell transplantation for standart risk leukemia: experience of Ibni Sina Hospital. Bone Marrow Transplantation, 25, 1229-1232, 2000.

  43. M.Beksaç, M.Arat, H.Akan, H.Koç, O.İlhan, M.Özcan. Circulating CD44 and Intracelluler adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic lekemia patients during interferon alfa-2a treatment. Cancer 89; 1974-1481, 2000

  44. G.Gürman, İ.Dilek, Ö.Arslan, M.Arat, M.Beksaç, O.İlhan, M.Özcan, H.Akan, K.Dalva, N.Konuk, A.Uysal, H.Koç The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfusion and Apheresis Science 24(1): 23-28, 2001

  45. G.Gürman, H.Çelebi, C.Üstün, M.Arat, O.İlhan, M.Özcan, Ö.Arslan, A.Uysal, H.Akan, M.Beksaç, N.Konuk, H.Koç Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Therapeutic Apheresis 5(1):54-57, 2001.

  46. M.Çetin, B.Eser, Ö.Er, A.Ünal, E.Kılıç, T.Patıroğlu, H.Senol Coşkun, M.Altınbaş, Ö.Arslan, O.İlhan Effects of DMSO on Platelet Functions and P-Selectin expression during Storage. Trasnfusion and Apheresis Science 24(2): 2001

  47. Arat M., İlhan O, Akçağlayan E, Çelebi H, Koç H, Akan H. Treatment of extensive chronic scleradermatous graft-versus-host disease with high dose immunosupressive therapy and CD34+ autologous stem cell rescue. Blood 2001;98:892 (letter)

  48. R. İdilman, C Üstün, Ö Arslan, M Özcan, M Arat, H Bozkaya, M Bozdayı, T Şengezer, Ö Uzunalimoğlu, A Dökmeci, O İlhan, H Koç, H Akan. The incidence of Hepatitis G Virusin patients with hematological malignancies:The relationship to the number of blood and blood products transfusions. Turkish Journal of Hematology 2000;17:67-76

  49. O İlhan, Ş.Mine Bakanay, M.Arat, M.Özcan, H.Çelebi, G.Gürman, Ö.Arslan, H.Akan, C.Üstün, E.Akçağlayan, N.Konuk, A.Uysal, H.Koç. Treatment of Aplastic Anemia: Experience of Ibni Sina Hospital. Turk J Hematol 2001; 18(1): 33-40.

  50. An usual presentation of plasma cell dyscrasias: Cardiac Tamponade due to myelomatous infiltration. (Case report)M.Arat, V.Ulusoy, T.Demirer, A.Uysal, M.Özcan, S.Dinçer, O İlhan, H.Koç. Leukemia&Lymphoma, 2002, 43: 145-148.

  51. Influence of Storage Time on Activation of Platelets Collected with CS 3000 Plus and Cobe Spectra Using Platelet Storage Containers : Sim Kutlay, Osman İlhan, Önder Arslan and Meral Beksaç. İnternational Society for Apheresis, 2002; 6(1):82-85.

  52. C.Üstün, M.Arat, Ç. Harika, H.Akan, O.İlhan, T.Özçelik, R.E.Burgess, H.Koç. Extramedullary relapse following allogeneic sem cell transplantation in acute promyelocytic leukemia: the role of ATRA. Haematologica. 2001. Oct; 86 (10): E31.

  53. M.Özcan, C.Üstün, E.Akçağlayan, H.Akan, Ö.Arslan, O.İlhan, M.Beksaç, G.Gürman, T.Demirer, M.Arat, H.Çelebi, N.Konuk, A.Uysal, H.Koç. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001 Mar; 27 (5): 499-505.

  54. G.Gürman, H.Çelebi, C.Üstün, M.Arati O.İlhan, M.Özcan, Ö.Arslan, A.Uysal, H.Akan, M.Beksaç, N.Konuk, H.Koç. Allogeneic peripheral blood stem cell transplantation for sever aplastic anemia. Ther Apher. 2001. Feb; 5 (1): 54-7

  55. G.Gürman, M.Arat, O.İlhan, N.Konuk, M.Beksaç, H.Çelebi, M.Özcan, Ö.Arslan, H.Akan, A.Uysal, H.Koç, Allogeneic hematopoietic cell transplantation without myeloblative conditioning for patients with advanced hematologic malignancies. Cytotherapy 2001; 3(4): 253-260.

  56. T.Demirer, O.İlhan, M.Arat, Y.Genç, M.Özcan, K.Dalva, H.Çelebi, M.Beksaç, H.Akan, G.Gürman, N.Konuk, A.Uysal, Ö.Arslan, H.Koç. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J.Clin Apheresis. 2001; 16 (2): 67-73.

  57. G.Gürman, İ.Dilek, Ö.Arslan,M.Arat, M.Beksaç, O.İlhan, M.Özcan, H.Akan, K.Dalva, N.Konuk, A.Uysal, H.Koç. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfus Apheresis Sci. 2001 Feb; 24(1): 23-8.

  58. M.Çetin, B.Eser, Ö.ER, a.Ünal, E.Kılıç, T.Patıroğlu, H.S.Coşkun, M.Aştınbaş, Ö.Arslan, O.İlhan. Effects of DMSO on platelet functions and P-selectin expression during storeage. Transfusion and Apheresis Science 2001; 24(3), 261-7.

  59. M.Arat, O.İlhan, E.Akçağlayan, H.Çelebi, H.Koç, H.Akan. Treatment of extensive chronc sclerodermatous graft-versus-host disease with high-dose immunosuppresive therapy and CD34+ autologous stem cell rescue. Blood. 2001. Aug 1;98(3): 892-3.

  60. M.Arat, M.Beksaç, G.Gürman, M.Özcan, Ö.Arslan, E.Soydan, D.Yazman, P.Topçuoğşu, O.İlhan, H.Koç, A.Uysal, N.Konuk, H.Akan. Allogeneic hematopoietic stem cell transplantation using iv Busulfan. Blood 98(11): 342b, 2001.

  61. An usual presentation of plasma cell dyscrasias: Cardiac Tamponade due to myelomatous infiltration. (Case report)M.Arat, V.Ulusoy, T.Demirer, A.Uysal, M.Özcan, S.Dinçer, O İlhan, H.Koç. Leukemia&Lymphoma, 2002, 43: 145-148.

  62. Influence of Storage Time on Activation of Platelets Collected with CS 3000 Plus and Cobe Spectra Using Platelet Storage Containers : Sim Kutlay, Osman İlhan, Önder Arslan and Meral Beksaç. İnternational Society for Apheresis, 2002; 6(1):82-85

  63. H.Akan, M.Beksaç, İ.Aydoğdu, H.Koç, O.İlhan, M.Özcan. Peripheral T cell receptors ?ß and ?? in patients with hodgkin's lymphoma. British Journal of Haematology 87: 544-547, 1994.

  64. O.İlhan, A.Uysal, İ.Aydoğdu, M.Beksaç, H.Akan, H.Koç. Mtoxantrone ancd cystosine arabinoside in previousy untreated patients with acute non-lymphomatic leukemia. Haematologia 27: 93-97, 1996.

  65. İ.Aydoğdu, O.İlhan, M.Beksaç, H.Koç, H.Akan, N.Konuk, A.Uysal,. Serum erythropoietin levels in patients with leukemia on cytostatic treatment. Haematologia 29:133-137, 1998.

  66. T.Demirer, M.Aylı, M.Özcan, M.Günel, R.Haznedar, M.Dağlı, T.Fen, S.Dinçer, Ö.Arslan, G.Gürman, S.Demirer, G.Özet, A.Uysal, N.Konuk, O.İlhan, H.Koç, H.Akan. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol. Feb; 116(2): 468-474, 2002.

  67. S.Kutlay, O.İlhan, ÖçArslan, M.Beksaç,. Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers. Ther Apher Feb 6 (1): 182-185, 2002.

  68. T.Demirer, M.Dağlı, O.İlhan, M.Aylı, R.Haznedar, T.Fen, N.Günel, Y.Genç, M.Arat, M.Özcan, Ö.Arslan, E.Seyrek, S.Dinçer, T.Üstün, N.Ustael, H.Koç, O.Müftüoğlu, H.Akan. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplant 29; 893-897, 2002.

  69. T.Demirer, O.İlhan, M.Aylı, M.Arat, M.Dağlı, M.Özcan, R.Haznedar, Y.Genç, T.Fen, E.Ayyıldız, S.Dinçer, Ö.Arslan, G.Gürman, N.Konuk, K.Dalva, A.Uysal, H.Koç, G.Özet, H.Akan. Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient cell yield. Therapeutic Apheresis 6(5): 284-389, 2002.

  70. İ.Tek, Ö.Arslan, M.Arat, M.Özcan, B.Akbağ, O. İlhan. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange. Transfusion and Apheresis Science 28; 3-7, 2003.

  71. M.Beksaç, H.Çelebi, H.Sargın, A.Yalçın, P.Topçuoğlu, S.Kalayoğlu-Beşışık, C.Beyan, Ö.Arslan, M.Özcan, G. Gürman, O.İlhan, H.Akan. Role of pretransplantinterferan-alpha (IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogeneous leukemia (CML): results form three Turkish transplant centers. Bone Marrow Transplant 31; 897-904, 2003.

  72. A.E.Ünal, S.Bayar, M.Arat, O.İlhan. Malpositioning of Hickman catheters, left versus right sides attempts. Transfusion and Apheresis Science 28 (1): 3-9, 2003.

  73. Tek I, Arslan O, Arat M, Ozcan M, Akdag B, Ilhan O. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange.
    Transfus Apheresis Sci. 2003 Feb;28(1):3-7.C

  74. Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
    Bone Marrow Transplant. 2003 May;31(9):755-61. A

  75. Beksac M, Celebi H, Sargin D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.Bone Marrow Transplant. 2003 May;31(10):897-904.A

  76. O. Ilhan, Ö. Arslan, M. Arat, E. Ayyildiz, M. Özcan, G. Gürman, T. Demirer, M. Beksac, N. Konuk, A. Uysal, H. Akan. Lessons from the activity of a single center between 1997-2002: Prof. Dr. Orhan Seyfi Şardaş hemapheresis unit experience. Blood Banking and Transfusion Medicine 2003;1(Supl 1):S298 (sözlü bildiri)

  77. Ö. Arslan, M. Arat, E. Soydan, H. Şenol Coşkun, P. Topçuoğlu, M Özcan, G. Gürman, T. Demirer, O. İlhan, H. Koç, M. Beksaç, N. Konuk, A. Uysal, H. Akan. Does donor recipient ABO-incompatibility have any effect the course and outcome of allogeneic hematopoietic stem cell transplantation? Blood Banking and Transfusion Medicine 2003;1(Supl 1):S292 (sözlü bildiri)

  78. M.Arat, P. Topcuoglu, E.A. Soydan, G. Gürman, M. Ozcan, O. Arslan, H. Koc, O. Ilhan, N. Konuk, A. Uysal, H. Akan, M. Beksac A retrospective comparison of oral versus intravenous administration of Busulfan: Preliminary results show similar toxicity but less relapse. Bone Marrow Transplant 2003; 31 (Suppl 1): S:20 (0171) (sözlü bildiri)

  79. EA. Soydan, M. Arat, P. Topçuoğlu, Ö. Arslan, M. Özcan, D. Ergintürk, G. Gürman, O. Ilhan, M. Beksaç, H. Akan. Allojeneik hemapoietik hücre nakli sonrası ekstra medüller nüks: tek merkez deneyimi. Turkish J Haematol 2003; 20 (Suppl): 98-99

  80. M. Arat, Ö. Arslan, E. Ayyıldız, M. Tol, O. İlhan. Performance of four different cell separators used at allogeneic hemapoietic progenitor cell collection. Blood Banking and Transfusion Medicine 2003;1(Supl 1):S356

  81. M. Arat, H. Akan, E. Ayyildiz, Ö. Arslan, O. İlhan. Comparison of vapor phase vs controlled rate freezing using HES and DMSO in three different formulations in stem cell cryopreservation (Tübitak-SBAG project no: 2189). Blood Banking and Transfusion Medicine 2003;1(Supl 1):S339

  82. M. Beksac, M. Arat, K. Dalva, O. Ilhan, S.K. Toprak, G. Gurman, M. Ozcan, O. Arslan, N. Konuk, A. Uysal, H. Akan CompArative analysis of molecular response following interferon-alpha, imatinib mesilate or allogeneic stem cell transplantation (ASCT): best response is obtained with ASCT in chronic myeloid leukemia. Bone Marrow Transplant 2003; 31 (Suppl 1): S:20 (P619)

  83. M. Arat, H. Akan, E. Ayyildiz, Ö. Arslan, O. Ilhan .Comparison of vapor phase vs controlled rate freezing using HES and DMSO in three different formulations for stem cell cryopreservation (TÜBITAK-SBAG Project No: 2189) Bone Marrow Transplant 2003; 31 (Suppl 1): S201 (P708)

  84. O. Ilhan, S.B. Kalayoglu, A. Ünal, M. Arat, Ö. Arslan, D. Sargin, M. Cetin, E. Ayyildiz, M. Özcan, G. Gürman, M. Beksac, H. Akan. Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease: Turkish experience. Bone Marrow Transplant 2003; 31 (Suppl 1): S136 (P562)

  85. E. Ayyildiz, M. Arat, Ö. Arslan, I. Tek, S. Gürpinar, S. Yildirim, K. Mizrak, M. Tol, O. Ilhan. Hemapheresis-related early complications during peripheral blood stem cell collections. Bone Marrow Transplant 2003; 31 (Suppl 1): S168 (P627)

  86. T. Demirer, M. Ayli, O. Ilhan, H. Koc, M. Dagli, M. Arat, T. Fen, S. Dincer, G. Ozet, H. Akan, A. Uysal. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplant 2003; 31 (Suppl 1): S195 (P695)

  87. E.A. Soydan, R. Idilman, M. Arat, S. Karayalcin, C. Ustun, M. Ozcan, O. Arslan, M. Beksac, O. Ilhan, H. Akan. The effect of hepatitis B virus status of donor on the hepatitis B virus serology of recipient after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2003; 31 (Suppl 1): S:95 (P470)

  88. E.A. Soydan, M. Arat, P. Topcuoglu, M. Ozcan, O. Arslan, R. Idilman, G. Gurman, M. Beksac, H. Akan, O. Ilhan The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease. Bone Marrow Transplant 2003; 31 (Suppl 1): S135 (P561)

  89. T Demirer,E Soydan,Maylı O İlhan,Mözcan M Dağlı Lenfoma olgularımızda yüksek doz tiyotepa,melphalan, carboplatin (MCB) sonrası Otolog Kök Hücre Nakli T.Demiere+Numune Hastanesi Turkish J Haematol 2003; 20 (Suppl)

  90. Kutlay S,Beksaç M,Dalva K,ilhan O,Koç H,Akan H,Ozcan M. The Detection of Flow Cytometric G-CSF Receptor Expression and İts Effect on Therapy in Acute Myeloid Leukemia Leukemia & Lymphoma 44(5),791-5,2003


[Başa Dön]